J 2013

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

PAGANO, Livio; Oliver A. CORNELY; Alessandro BUSCA; Morena CAIRA; Simone CESARO et. al.

Základní údaje

Originální název

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.

Autoři

PAGANO, Livio; Oliver A. CORNELY; Alessandro BUSCA; Morena CAIRA; Simone CESARO; Cristiana GASBARRINO; Corrado GIRMENIA; Werner J. HEINZ; Raoul HERBRECHT; Cornelia LASS-FLÖRL; Annamaria NOSARI; Leonardo POTENZA; Zdeněk RÁČIL; Volker RICKERTS; Donald C. SHEPPARD; Arne SIMON; Andrew J. ULLMAN; Caterina Giovanna VALENTINI; Jörg Janne VEHRESCHILD; Anna CANDONI a Maria J.G.T. VEHRESCHILD

Vydání

Haematologica, Pavia, ITALY, Ferrata Storti Foundation, 2013, 0390-6078

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Itálie

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.868

Kód RIV

RIV/00216224:14740/13:00069044

Organizační jednotka

Středoevropský technologický institut

UT WoS

000328543400002

Klíčová slova anglicky

posaconazole; lipid fomulations of amphotericin B; Mucormycosis; combination therapy; invasive fungal infections; hematological malignancies

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 28. 4. 2014 16:01, Olga Křížová

Anotace

V originále

Our case series may have been subject to selection bias, as only those patients who survived long enough to receive a combination therapy were included. However, since interventional trials on this question are unlikely to be performed any time soon, data from registries remain the only available source of structured information on the treatment of mucormycosis. In conclusion, our analysis suggests that a combined antifungal treatment with Lip-AmB+POS may be considered in patients with very aggressive forms of IM.